Hugo Biotech
About:
Hugo Biotech has conducted the sequencing of nearly 20,000 clinical samples for over 300 first class hospitals in china.
Website: https://www.hugobiotech.com/
Top Investors: Sinovation Ventures, Northern Light Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund, LYFE Capital, CD Capital
Description:
Hugo Biotech has conducted the sequencing of nearly 20,000 clinical samples for over 300 first class hospitals in china.
Total Funding Amount:
818M CNY
Headquarters Location:
Beijing, Beijing, China
Founded Date:
2017-01-01
Founders:
Han Xia
Number of Employees:
101-250
Last Funding Date:
2022-01-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai